Enozertinib is an investigational new drug that is being developed by Voronoi for the treatment of solid tumors and non-small cell lung cancer. It is a EGFR receptor antagonist.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.